Results 231 to 240 of about 25,306 (274)
Some of the next articles are maybe not open access.
Differentiation of atypical Parkinson syndromes
Journal of Neural Transmission, 2017In distinction to idiopathic Parkinson's disease (PD), the diagnosis of atypical Parkinson syndromes comprises dementia with Lewy bodies (DLB), multiple system atrophy (MSA), progressive supranuclear palsy (PSP), and corticobasal degeneration (CBD). We set out to write a state-of-the-art guideline as to which investigations and examinations help to ...
Günter U. Höglinger +7 more
openaire +3 more sources
Functional MRI in Atypical Parkinsonisms
2018The present chapter reports the current knowledge on the use of functional MRI (fMRI) in patients with atypical parkinsonisms, including Multiple System Atrophy, Corticobasal Syndrome and Progressive Supranuclear Palsy syndrome. Both resting state functional connectivity and task-based brain activity abnormalities are reported in atypical parkinsonisms
Agosta F, Sarasso E, Filippi M
openaire +3 more sources
Interventional trials in atypical parkinsonism
Parkinsonism & Related Disorders, 2016Atypical parkinson disorders (APD) are rapidly progressive neurodegenerative diseases with a variable clinical presentation that may even mimic Parkinson's disease. Multiple system atrophy (MSA), progressive supranuclear palsy (PSP) and corticobasal degeneration (CBD) are commonly summarized under this umbrella term.
S, Eschlböck, F, Krismer, G K, Wenning
openaire +2 more sources
Autoimmune atypical parkinsonism — A group of treatable parkinsonism
Journal of the Neurological Sciences, 2016Immunological causes of atypical parkinsonism/Parkinson plus syndromes are rare.To study the clinical and laboratory features and treatment outcome of autoimmune atypical parkinsonism.Retrospective case series. Patients with atypical parkinsonism and positive antibodies were identified retrospectively.
Sudheeran, Kannoth +4 more
openaire +2 more sources
The “bicycle sign” for atypical parkinsonism
The Lancet, 2011Aerts, M B Abdo, W F Bloem, B R Letter Research Support, Non-U.S. Gov't England Lancet. 2011 Jan 8;377(9760):125-6.
Aerts, M.B. +3 more
openaire +3 more sources
Structural Imaging in Atypical Parkinsonism
2018Qualitative and quantitative structural magnetic resonance imaging offer objective measures of the underlying neurodegeneration in atypical parkinsonism. Regional changes in tissue volume, signal changes and increased deposition of iron as assessed with different structural MRI techniques are surrogate markers of underlying neurodegeneration and may ...
Beatrice, Heim +2 more
openaire +2 more sources
[Atypical Parkinson syndrome].
Der Nervenarzt, 1997Various clinico-pathological studies have shown that appr. 20% of patients with a clinical diagnosis of idiopathic Parkinson's disease (IPD) may have neuropathological evidence of alternative causes of parkinsonism. Most of these misdiagnosed "IPD" patients meet clinical criteria for either multiple system atrophy (MSA), or progressive supranuclear ...
G K, Wenning +3 more
openaire +1 more source
[Atypical Parkinson syndromes].
Der Nervenarzt, 2009At the moment atypical Parkinson syndromes have unfavorable prognoses and show little response to dopaminergic medication. Early differential diagnosis of these disorders from idiopathic Parkinson syndrome is of pivotal clinical relevance. In case of future causal, neuroprotective therapeutic strategies, early diagnosis will allow a timely start of ...
A, Strzelczyk +4 more
openaire +1 more source
Phenomenology of Atypical Parkinsonism
2020Atypical parkinsonism includes three main disorders, progressive supranuclear palsy, multiple system atrophy, and corticobasal syndrome. Each of these disorders has a rich and distinct history in neurology, and clinical examination and management of these challenging patients requires careful attention to the movement disorder history and phenomenology.
Steven J. Frucht, Pichet Termsarasab
openaire +1 more source
Extrapyramidal Diseases: Atypical Parkinsonisms
2015Atypical parkinsonisms (AP) encompass a polymorphic group of neurodegenerative disorders, namely, progressive supranuclear palsy (PSP), multisystem atrophy (MSA), and cortical-basal degeneration (CBD).
Marco Prastaro, Floriano Girotti
openaire +1 more source

